Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid.

Liu J, Killilea DW, Ames BN.

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1876-81. Erratum in: Proc Natl Acad Sci U S A 2002 May 14;99(10):7184.

2.
3.

Delaying the mitochondrial decay of aging with acetylcarnitine.

Ames BN, Liu J.

Ann N Y Acad Sci. 2004 Nov;1033:108-16. Review.

PMID:
15591008
4.

Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites.

Liu J, Atamna H, Kuratsune H, Ames BN.

Ann N Y Acad Sci. 2002 Apr;959:133-66. Review.

PMID:
11976193
5.

Acetyl-L-carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere.

Carta A, Calvani M, Bravi D, Bhuachalla SN.

Ann N Y Acad Sci. 1993 Sep 24;695:324-6. Review.

PMID:
8239306
7.

Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders?

Soczynska JK, Kennedy SH, Chow CS, Woldeyohannes HO, Konarski JZ, McIntyre RS.

Expert Opin Investig Drugs. 2008 Jun;17(6):827-43. doi: 10.1517/13543784.17.6.827 . Review.

PMID:
18491985
8.

Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.

Zanelli SA, Solenski NJ, Rosenthal RE, Fiskum G.

Ann N Y Acad Sci. 2005 Aug;1053:153-61. Review.

9.

Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?

Rosca MG, Lemieux H, Hoppel CL.

Adv Drug Deliv Rev. 2009 Nov 30;61(14):1332-42. doi: 10.1016/j.addr.2009.06.009. Epub 2009 Aug 29. Review.

Supplemental Content

Support Center